Search Results - Scott L Friedman
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome by Scott L. Friedman
Published 2024-03-01
Article -
2
A Sabbatical: The Gift That Keeps on Giving by Scott L. Friedman, MD
Published 2018-01-01
Article -
3
-
4
The role of chemokines in acute liver injury by Yedidya eSaiman, Scott L. Friedman
Published 2012-06-01
Article -
5
Megatrends in bile acid receptor research by Luciano Adorini, Kristina Schoonjans, Scott L. Friedman
Published 2017-10-01
Article -
6
Hepatic Stellate Cell-Immune Interactions in NASH by James K. Carter, James K. Carter, Scott L. Friedman
Published 2022-06-01
Article -
7
-
8
-
9
-
10
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models by Marie O’Farrell, Greg Duke, Richard Crowley, Douglas Buckley, Eduardo B. Martins, Dipankar Bhattacharya, Scott L. Friedman, George Kemble
Published 2022-09-01
Article -
11
-
12
-
13
-
14
Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis by Dipankar Bhattacharya, Christine Becker, Benjamin Readhead, Nicolas Goossens, Jacqueline Novik, Maria Isabel Fiel, Leslie P. Cousens, Björn Magnusson, Anna Backmark, Ryan Hicks, Joel T. Dudley, Scott L. Friedman
Published 2021-10-01
Article -
15
Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells by Kavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, Kimberly Izarraras, Tia Hart, Brent Mayfield, Maryjka B. Blaszczyk, Zhongren Zhou, Utpal B. Pajvani, Scott L. Friedman, Moshmi Bhattacharya
Published 2024-10-01
Article -
16
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis by Dipankar Bhattacharya, Brittany Basta, Jose M. Mato, Amanda Craig, David Fernández-Ramos, Fernando Lopitz-Otsoa, Darya Tsvirkun, Liat Hayardeny, Vasuretha Chandar, Robert E. Schwartz, Augusto Villanueva, Scott L. Friedman
Published 2021-06-01
Article -
17
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6 by Ben L. Da, Tatyana Kushner, Maan El Halabi, Pavan Paka, Mian Khalid, Angad Uberoi, Brian T. Lee, Ponni V. Perumalswami, Stephanie M. Rutledge, Thomas D. Schiano, Scott L. Friedman, Behnam Saberi
Published 2021-02-01
Article -
18
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis. by Eric Lefebvre, Graeme Moyle, Ran Reshef, Lee P Richman, Melanie Thompson, Feng Hong, Hsin-L Chou, Taishi Hashiguchi, Craig Plato, Dominic Poulin, Toni Richards, Hiroyuki Yoneyama, Helen Jenkins, Grushenka Wolfgang, Scott L Friedman
Published 2016-01-01
Article -
19
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis by Katherine Martin, James Pritchett, Jessica Llewellyn, Aoibheann F. Mullan, Varinder S. Athwal, Ross Dobie, Emma Harvey, Leo Zeef, Stuart Farrow, Charles Streuli, Neil C. Henderson, Scott L. Friedman, Neil A. Hanley, Karen Piper Hanley
Published 2016-08-01
Article -
20
Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular SecretionSummary by Xiaojie Yu, Natalia Elfimova, Marion Müller, Daniel Bachurski, Ulrike Koitzsch, Uta Drebber, Esther Mahabir, Hinrich P. Hansen, Scott L. Friedman, Sabine Klein, Hans Peter Dienes, Marianna Hösel, Reinhard Buettner, Jonel Trebicka, Vangelis Kondylis, Inge Mannaerts, Margarete Odenthal
Published 2022-01-01
Article